To further characterize their expression in MM, we used immunohistochemistry evidence from the HPA (Human Protein Atlas) database to demonstrate that CSNK1E was substantially increased in melanoma compared to normal skin tissue (Figures 9(a)–9(d)). This evidence concerns the gene CSNK1E and Miyoshi myopathy.